Rui Castro studies the mechanisms behind the development of metabolic liver disease, new forms of diagnosis and possible treatments, with the collaboration of three international partners from the Federal Polytechnic School of Lausanne (Switzerland), the Biodonostia Health Research Institute and the Center for Cooperative Research in Biosciences, both in the Basque Country (Spain). Cecília Rodrigues investigates new therapeutic targets that allow controlling the most common liver disease worldwide.
On October 8, the two scientists from the Medicines Research Institute, of the Faculty of Pharmacy of the University of Lisbon, will talk with journalist Paulo Farinha about the challenges of the work they are doing, what this could mean in the future. future and how it is related to problems such as obesity or diabetes.
You can follow this “practical class” here.
This article is part of a series on cutting-edge scientific research and is a collaboration between Observador, the “la Caixa” Foundation and BPI.